Speech disorders and axial motor impairment in advanced Parkinson’s Disease: two sides of the same coin?
Objective: To examine possible correlations between axial motor features, disease severity and speech parameters in advanced Parkinson’s Disease (PD) patients and to evaluate chronic dopaminergic…Clinical Manifestations of Metabolic Syndrome in Parkinson’s Disease – Report from Indonesia Tertiary Referral Hospital
Objective: The study aims to determine the prevalence of metabolic syndrome and related factors in Parkinson's disease (PD). Background: Parkinson's disease is a neurodegenerative disorder,…Long-read nanopore sequencing for cost-effective and comprehensive analysis of GBA mutations in Norwegian patients with Parkinson’s disease
Objective: To use nanopore sequencing as a cost-effective strategy to determine the association and prevalence of mutations within the GBA gene in patients with Parkinson’s disease (PD) from the Norwegian population.…Central oscillation in the basal ganglia during re-emergent tremor pause in Parkinson’s Disease
Objective: To correlate central oscillation in the basal ganglia with EMG activity during re-emergent tremor pause. Background: According to the dimmer-switch model, basal ganglia act…Combining intraoperative microelectrode recordings with postoperative transcranial B-mode sonography of the brainstem to estimate the anatomical position of the electrode for chronic subthalamic nucleus deep brain stimulation in Parkinson´s disease
Objective: We tested whether the position of the electrode for deep brain stimulation (DBS) could be assessed relative to subthalamic nucleus (STN) dorsal boundaries by…Spinal cord stimulation for gait problems in Parkinson´s disease: Long term report and placebo viability
Objective: In the present study we set out to report a very long-term follow-up period of spinal cord stimulation (SCS) for Parkinson's Disease (PD) patients…Knowledge and attitude of Egyptian general public towards Parkinson disease: A cross-sectional study in Egypt.
Objective: We aim to investigate the public Egyptian knowledge and attitude towards PD. Background: In Egypt, the PD prevalence reached 316.50 per 100,000 people. Given…Psychometric characteristics of the Neuropsychiatric Fluctuation Scale
Objective: To evaluate the psychometric properties of the Neuropsychiatric fluctuation scale (NFS) for Parkinson’s disease (PD). Background: Neuropsychiatric fluctuations (NpsyF) in PD are frequent and…Quality of life and patient reported outcomes with subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 BeyoND study
Objective: To review quality of life and other patient reported outcomes data from the ND0612 BeyoND study. Background: ND0612 is in development as a continuous,…Impact of istradefylline on the adjustment of levodopa dose escalation in Parkinson’s disease: Results of the ISTRA ADJUST PD randomized, controlled study
Objective: To evaluate the effect of istradefylline (IST), an adenosine A2A receptor antagonist, on the adjustment of levodopa dose escalation in patients with Parkinson’s disease…
- « Previous Page
- 1
- …
- 300
- 301
- 302
- 303
- 304
- …
- 436
- Next Page »